Cited by 356Economic and Financial Impacts of CancerCancer survivorship and careCancer Treatment and Pharmacology

The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.

The Time Toxicity of Cancer Treatment

Gupta, Arjun, Eisenhauer, Elizabeth A., Booth, Christopher M.·2022·Journal of Clinical Oncology

DOI 10.1200/jco.21.02810

Open this paper in CoChat — free account

Integrity signals

Registry

Crossref · 10.1200/jco.21.02810

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043330 · Cited by 21,807
Self-citation
MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma
Hegi, M. E., Diserens, A.-C., Gorlia, T., Hamou, M.-F., de Tribolet, N., Weller, M., Kros, J. M., Hainfellner, J. A., Mason, W., Mariani, L., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043331 · Cited by 7,405
Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness
The ESCAPE Investigators and ESCAPE Study Coordinators* (2005) · JAMA · doi:10.1001/jama.294.13.1625 · Cited by 1,544
Balanced Crystalloids versus Saline in Noncritically Ill Adults
Self, W. H., Semler, M. W., Wanderer, J. P., Wang, L., Byrne, D. W., Collins, S. P., Slovis, C. M., Lindsell, C. J., Ehrenfeld, J. M., Siew, E. D., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1711586 · Cited by 1,170
Prasugrel versus clopidogrel for acute coronary syndromes without revascularization
Roe, M. T., Armstrong, P. W., Fox, K. A. A., White, H. D., Prabhakaran, D., Goodman, S. G., Cornel, J. H., Bhatt, D. L., Clemmensen, P., Martinez, F., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1205512 · Cited by 874
Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial
Lamarca, Á., Palmer, D. H., Wasan, H. S., Ross, P. J., Ma, Y. T., Arora, A., Falk, S. J., Gillmore, R., Wadsley, J., Patel, K., et al. (2021) · The Lancet Oncology · doi:10.1016/s1470-2045(21)00027-9 · Cited by 781
NXY-059 for Acute Ischemic Stroke
Lees, K. R., Zivin, J. A., Ashwood, T., Davalos, A., Davis, S. M., Diener, H.-C., Grotta, J., Lyden, P., Shuaib, A., Hårdemark, H.-G., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052980 · Cited by 660
Physical rehabilitation for older patients hospitalized for heart failure
Kitzman, D. W., Whellan, D. J., Duncan, P., Pastva, A. M., Mentz, R. J., Reeves, G. R., Nelson, M. B., Chen, H., Upadhya, B., Reed, S. D., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2026141 · Cited by 594
Unintended Consequences of Expensive Cancer Therapeutics—The Pursuit of Marginal Indications and a Me-Too Mentality That Stifles Innovation and Creativity
Fojo, T., Mailankody, S., & Lo, A. W. (2014) · JAMA Otolaryngology–Head & Neck Surgery · doi:10.1001/jamaoto.2014.1570 · Cited by 309
Days Spent at Home — A Patient-Centered Goal and Outcome
Groff, A. C., Colla, C. H., & Lee, T. H.-Y. (2016) · New England Journal of Medicine · doi:10.1056/nejmp1607206 · Cited by 272
Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia
The COVID STEROID 2 Trial Group, Russell, L., Uhre, K. R., Lindgaard, A. L. S., Degn, J. F., Wetterslev, M., Sivapalan, P., Anthon, C. T., Mikkelsen, V. S., la Porta, L. C., et al. (2021) · JAMA · doi:10.1001/jama.2021.18295 · Cited by 260
Days Alive and Out of Hospital
Jerath, A., Austin, P. C., & Wijeysundera, D. N. (2019) · Anesthesiology · doi:10.1097/aln.0000000000002701 · Cited by 228
Evolution of the Randomized Clinical Trial in the Era of Precision Oncology
Paggio, J. C. D., Berry, J. S., Hopman, W. M., Eisenhauer, E. A., Prasad, V. K., Gyawali, B., & Booth, C. M. (2021) · JAMA Oncology · doi:10.1001/jamaoncol.2021.0379 · Cited by 211
Self-citation
Days alive and out of hospital and the patient journey in patients with heart failure: Insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program
Ariti, C. A., Cleland, J. G. F., Pocock, S., Pfeffer, M. A., Swedberg, K. B., Granger, C. B., McMurray, J. J. V., Michelson, E. L., Östergren, J., & Yusuf, S. (2011) · American Heart Journal · doi:10.1016/j.ahj.2011.08.003 · Cited by 193
Days at Home after Surgery: An Integrated and Efficient Outcome Measure for Clinical Trials and Quality Assurance
Bell, M., Eriksson, L. I., Svensson, T., Hallqvist, L., Granath, F. N., Reilly, J. R., & Myles, P. S. (2019) · EClinicalMedicine · doi:10.1016/j.eclinm.2019.04.011 · Cited by 154
Hospital-Free Days: A Pragmatic and Patient-centered Outcome for Trials among Critically and Seriously Ill Patients
Auriemma, C. L., Taylor, S. P., Harhay, M. O., Courtright, K. R., & Halpern, S. D. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202104-1063pp · Cited by 140
At What Cost to Clinical Trial Enrollment? A Retrospective Study of Patient Travel Burden in Cancer Clinical Trials
Borno, H. T., Zhang, L., Siegel, A. P., Chang, E. G., & Ryan, C. J. (2018) · The Oncologist · doi:10.1634/theoncologist.2017-0628 · Cited by 125
Home-Time After Discharge Among Patients Hospitalized With Heart Failure
Greene, S. J., O'Brien, E. C., Mentz, R. J., Luo, N., Hardy, N. C., Laskey, W. K., Heidenreich, P. A., Chang, C.-L., Turner, S. J., Yancy, C. W., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.03.517 · Cited by 116
Healthy Days at home: A novel population-based outcome measure
Burke, L. G., Orav, E. J., Zheng, J., & Jha, A. K. (2019) · Healthcare · doi:10.1016/j.hjdsi.2019.100378 · Cited by 100
Assessment of Home-Time After Acute Ischemic Stroke in Medicare Beneficiaries
Fonarow, G. C., Liang, L., Thomas, L. E., Xian, Y., Saver, J. L., Smith, E. E., Schwamm, L. H., Peterson, E. D., Hernandez, A. F., Duncan, P. W., et al. (2016) · Stroke · doi:10.1161/strokeaha.115.011599 · Cited by 97
Days Alive and Out of Hospital: Exploring a Patient-Centered, Pragmatic Outcome in a Clinical Trial of Patients With Acute Coronary Syndromes
Fanaroff, A. C., Cyr, D. D., Neely, M. L., Bakal, J. A., White, H. D., Fox, K. A. A., Armstrong, P. W., Lópes, R. D., Ohman, E. M., & Roe, M. T. (2018) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.118.004755 · Cited by 86
Patient-Centered Time-at-Home Outcomes in Older Adults After Surgical Cancer Treatment
Chesney, T. R., Haas, B., Coburn, N. G., Mahar, A. L., Zuk, V., Zhao, H., Wright, F. C., Hsu, A. T., & Hallet, J. I. (2020) · JAMA Surgery · doi:10.1001/jamasurg.2020.3754 · Cited by 76
Opportunity Costs of Receiving Palliative Chemotherapy for Metastatic Pancreatic Ductal Adenocarcinoma
Bange, E. M., Doucette, A. G., Gabriel, P. E., Porterfield, F., Harrigan, J. J., Wang, R., Wojcieszynski, A. P., Boursi, B., Mooney, B., Reiss, K. A., et al. (2020) · JCO Oncology Practice · doi:10.1200/jop.19.00328 · Cited by 73
Evaluation of Oncology Hospital at Home: Unplanned Health Care Utilization and Costs in the Huntsman at Home Real-World Trial
Mooney, K. H., Titchener, K., Haaland, B. A., Coombs, L. A., O'Neil, B. B., Nelson, R. E., McPherson, J. P., Kirchhoff, A. C., Beck, A. C., & Ward, J. H. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.20.03609 · Cited by 64
The Oncology Hospital at Home
Handley, N. R., & Bekelman, J. E. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.01167 · Cited by 61
Annual Patient Time Costs Associated With Medical Care Among Cancer Survivors in the United States
Yabroff, K. R., Guy, G. P., Ekwueme, D. U., McNeel, T. S., Rozjabek, H., Dowling, E. C., Li, C., & Virgo, K. S. (2014) · Medical Care · doi:10.1097/mlr.0000000000000151 · Cited by 60
Time-Related Burdens of Cancer Care
Gupta, A., Jensen, E. H., Virnig, B. A., & Beg, M. S. (2021) · JCO Oncology Practice · doi:10.1200/op.21.00662 · Cited by 57
Self-citation
Health care‐related time costs in patients with metastatic breast cancer
Rocque, G. B., Williams, C., Ingram, S. A., Azuero, A., Mennemeyer, S. T., Pierce, J. Y., Nipp, R. D., Reeder-Hayes, K. E., & Kenzik, K. M. (2020) · Cancer Medicine · doi:10.1002/cam4.3461 · Cited by 52
Home Time Is Extended in Patients With Ischemic Stroke Who Receive Thrombolytic Therapy
Mishra, N. K., Shuaib, A. M., Lyden, P. D., Diener, H., Grotta, J. C., Davis, S. M., Dávalos, A., Ashwood, T. J., Wasiewski, W. W., & Lees, K. R. (2011) · Stroke · doi:10.1161/strokeaha.110.601302 · Cited by 50
Hospital Length of Stay in the First 100 Days after Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia in Remission: Comparison among Alternative Graft Sources
Ballen, K. K., Joffe, S., Brazauskas, R., Wang, Z., Aljurf, M. D., Akpek, G., Dandoy, C. E., Frangoul, H., Freytes, C. O., Khera, N., et al. (2014) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2014.07.021 · Cited by 48
Has the Current Oncology Value Paradigm Forgotten Patients’ Time?
Fundytus, A. M., Prasad, V. K., & Booth, C. M. (2021) · JAMA Oncology · doi:10.1001/jamaoncol.2021.3600 · Cited by 46
Self-citation
Hospital Variation in Home-Time After Acute Ischemic Stroke
O'Brien, E. C., Xian, Y., Xu, H., Wu, J., Saver, J. L., Smith, E. E., Schwamm, L. H., Peterson, E. D., Reeves, M. J., Bhatt, D. L., et al. (2016) · Stroke · doi:10.1161/strokeaha.116.013563 · Cited by 43
Days out of Institution after Tracheostomy and Gastrostomy Placement in Critically Ill Older Adults
Law, A. C., Stevens, J. P., Choi, E., Shen, C., Mehta, A., Yeh, R. W., & Walkey, A. J. (2021) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202106-649oc · Cited by 32
Maximizing Home Time for Persons With Cancer
Banerjee, R. K., George, M., & Gupta, A. (2021) · JCO Oncology Practice · doi:10.1200/op.20.01071 · Cited by 31
Self-citation
Healthcare utilization after liver transplantation is highly variable among both centers and recipients
Bittermann, T., Hubbard, R. A., Serper, M., Lewis, J. D., Hohmann, S., VanWagner, L. B., & Goldberg, D. S. (2017) · American Journal of Transplantation · doi:10.1111/ajt.14539 · Cited by 28
Comparing regression modeling strategies for predicting hometime
Holodinsky, J. K., Yu, A., Kapral, M. K., & Austin, P. C. (2021) · BMC Medical Research Methodology · doi:10.1186/s12874-021-01331-9 · Cited by 25
Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial
Szarek, M. J., Steg, P. G., DiCenso, D., Bhatt, D. L., Bittner, V., Budaj, A., Díaz, R., Goodman, S. G., Gotcheva, N. N., Jukema, J. W., et al. (2019) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.119.005858 · Cited by 23
Opportunity Costs of Surgical Resection and Perioperative Chemotherapy for Locoregional Pancreatic Adenocarcinoma
Lim, S.-A., Hao, S. B., Boyd, B. A., Mitsakos, A. T., Irish, W. D., Burke, A. M., Parikh, A. A., & Snyder, R. A. (2021) · JCO Oncology Practice · doi:10.1200/op.21.00311 · Cited by 23
The Toxicity of Time
Daily, K. C. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.74.7907 · Cited by 19
Evaluation of Risk-Adjusted Home Time After Acute Myocardial Infarction as a Novel Hospital-Level Performance Metric for Medicare Beneficiaries
Pandey, A., Keshvani, N., Vaughan‐Sarrazin, M., Gao, Y., & Girotra, S. R. (2020) · Circulation · doi:10.1161/circulationaha.119.044765 · Cited by 19
Comparison of Days Alive Out of Hospital With Initial Invasive vs Conservative Management
White, H. D., O’Brien, S. M., Alexander, K. P., Boden, W. E., Bangalore, S., Li, J., Manjunath, C. N., Lopez-Sendon, J. L., Peteiro, J., Gosselin, G., et al. (2021) · JAMA Cardiology · doi:10.1001/jamacardio.2021.1651 · Cited by 18
Reducing Wait Time Between Admission and Chemotherapy Initiation
Gupta, A., Li, J., Tawfik, B., Pham, T. N., Pathak, S., Singh, P., Porsa, E., Sadeghi, N., & Li, H. C. (2018) · Journal of Oncology Practice · doi:10.1200/jop.17.00028 · Cited by 14
Self-citation
Time Spent Away from Home in the Year Following High‐Risk Cancer Surgery in Older Adults
Suskind, A. M., Zhao, S., Boscardin, W. J., Smith, A. K., & Finlayson, E. V. A. (2020) · Journal of the American Geriatrics Society · doi:10.1111/jgs.16344 · Cited by 14
Caregiver Burden #419
Sedhom, R., Samaan, A., & Gupta, A. (2021) · Journal of Palliative Medicine · doi:10.1089/jpm.2021.0244 · Cited by 10
Self-citation
Development of the Oncology Opportunity Cost Assessment Tool: Item Generation and Content Validity Testing
Handley, N. R., Binder, A. F., Heyer, A., Granberg, R. E., Davis, G., Nord, G., Gentsch, A. T., & Rising, K. L. (2021) · JCO Oncology Practice · doi:10.1200/op.21.00288 · Cited by 9
Risk-Standardized Home Time as a Novel Hospital Performance Metric for Pneumonia Hospitalization Among Medicare Beneficiaries: a Retrospective Cohort Study
Nair, R., Gao, Y., Vaughan‐Sarrazin, M., Perencevich, E. N., Girotra, S. R., & Pandey, A. (2021) · Journal of General Internal Medicine · doi:10.1007/s11606-021-06712-w · Cited by 8
Seeking patient-centered trial outcomes: The case for days alive out of hospital
Faggioni, M., & Fanaroff, A. C. (2021) · American Heart Journal · doi:10.1016/j.ahj.2021.04.016 · Cited by 8

Research works printed but not linked: 2

Penn Center for Cancer Care Innovation, Cancer Care @ Home
Penn Center for Cancer Care Innovation, Leveraging Digital Technologies to Reduce Time Burden for Patients with Advanced Cancer

Sorted by citations

Digital health and telehealth in cancer care: A scoping review of reviews
Shaffer, K. M., Turner, K. L., Siwik, C., Gonzalez, B. D., Upasani, R., Glazer, J. V., Ferguson, R. J., Joshua, C., & Low, C. A. (2023) · The Lancet Digital Health · doi:10.1016/s2589-7500(23)00049-3 · Cited by 263
“…by telephone and internet—via phone calls, videoconferencing, mobile applications, and web pages—can reduce the time burdens of cancer treatment 1 and extend access to evidence-based interventions for cancer prevention and control, surveillance, supportive care, treatment decision making, and…”
Patient-Reported Outcome Measures in Cancer Care
Balitsky, A. K., Rayner, D. G., Britto, J., Lionel, A. C., Ginsberg, L., Cho, W., Wilfred, A. M., Sardar, H., Cantor, N., Mian, H. S., et al. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.24793 · Cited by 134
Addressing Transportation Insecurity Among Patients With Cancer
Graboyes, E. M., Chaiyachati, K. H., Gall, J. S., Johnson, W., Krishnan, J. A., McManus, S. S., Thompson, L., Shulman, L. N., & Yabroff, K. R. (2022) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djac134 · Cited by 102
Oral decitabine–cedazuridine versus intravenous decitabine for myelodysplastic syndromes and chronic myelomonocytic leukaemia (ASCERTAIN): a registrational, randomised, crossover, pharmacokinetics, phase 3 study
Garcia‐Manero, G., McCloskey, J. K., Griffiths, E. A., Yee, K. W. L., Zeidan, A. M., Al‐Kali, A., Deeg, H. J., Patel, P. A., Sabloff, M., Keating, M., et al. (2023) · The Lancet Haematology · doi:10.1016/s2352-3026(23)00338-1 · Cited by 94
Evaluating the Time Toxicity of Cancer Treatment in the CCTG CO.17 Trial
Gupta, A., O'Callaghan, C. J., Zhu, L., Jonker, D. J., Wong, R. P. W., Colwell, B., Moore, M. J., Karapetis, C. S., Tebbutt, N. C., Shapiro, J. D., et al. (2023) · JCO Oncology Practice · doi:10.1200/op.22.00737 · Cited by 79
Self-citation

See all 356

Authors: Gupta, A., Eisenhauer, E. A., & Booth, C. M.
Affiliations: University of Minnesota (US)
Queen's University (CA)
ORCID: Gupta, Arjun
Booth, Christopher M.
Venue: Journal of Clinical Oncology
Publisher: American Society of Clinical Oncology (ASCO)
Published: 2022-05-20
Volume: 40
Issue: 15
Pages: 1611-1615
ISSN: 0732-183X (ISSN-L)
1527-7755
DOI: 10.1200/jco.21.02810
OpenAlex: W4214862515
Cited by: 356
References: 47
Citations by year: 2026: 108 · 2025: 94 · 2024: 85 · 2023: 55 · 2022: 13
FWCI: 49.67
Type: journal article
Language: en
Open access: closed
Locations: Journal of Clinical Oncology (publishedVersion)
PubMed (publishedVersion)
Topics: Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Economic and Financial Impacts of Cancer
Health Sciences › Medicine › Oncology › Cancer survivorship and care
Health Sciences › Medicine › Oncology › Cancer Treatment and Pharmacology
Keywords: time toxicity, cancer therapy, treatment toxicity, late effects of cancer treatment
MeSH terms: Humans, Neoplasms, Quality of Life

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Time Toxicity of Cancer Treatment

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks